PMA P010033S006

Device
QUANTIFERON -TB GOLD
Applicant
Qiagen
PMA number
P010033
Supplement
S006
Product code
NCD
Decision date
2004-12-02
Classification
Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis
Generic name
TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS
Approval order statement
APPROVAL FOR THE USE OF SYNTHETIC PEPTIDE ANTIGENS ESAT-6 AND CFP-10 AND REMOVAL OF THE TUBERCULIN PPD AND M. AVIUM PPD ANTIGENS USED IN THE QUANTIFERON - TB. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME QUANTIFERON - TB GOLD AND IS INDICATED FOR USE AS AN IN VITRO DIAGNOSTIC TEST USING PEPTIDE COCKTAILS SIMULATING ESAT-6 AND CFP-10 PROTEINS TO STIMULATE CELLS IN HEPARINIZED WHOLE BLOOD. DETECTION OF INTERFERON-Y BY ELISA IS USED TO IDENTIFY IN VITRO RESPONSES TO ESAT-6 AND CFP-10 THAT ARE ASSOCIATED WITH MYCOBACTERIUM TUBERCULOSIS INFECTION. THE DEVICE APPROVAL IS FOR USE OF AN 8-POINT CALIBRATION CURVE WITH MANUAL CALCULATIONS.

Current openFDA PMA Record#

Device
QUANTIFERON -TB GOLD
Applicant
Qiagen
PMA number
P010033
Supplement
S006
Product code
NCD
Generic name
TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS
Decision date
2004-12-02
Decision code
APPR
Date received
2003-12-04
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL FOR THE USE OF SYNTHETIC PEPTIDE ANTIGENS ESAT-6 AND CFP-10 AND REMOVAL OF THE TUBERCULIN PPD AND M. AVIUM PPD ANTIGENS USED IN THE QUANTIFERON - TB. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME QUANTIFERON - TB GOLD AND IS INDICATED FOR USE AS AN IN VITRO DIAGNOSTIC TEST USING PEPTIDE COCKTAILS SIMULATING ESAT-6 AND CFP-10 PROTEINS TO STIMULATE CELLS IN HEPARINIZED WHOLE BLOOD. DETECTION OF INTERFERON-Y BY ELISA IS USED TO IDENTIFY IN VITRO RESPONSES TO ESAT-6 AND CFP-10 THAT ARE ASSOCIATED WITH MYCOBACTERIUM TUBERCULOSIS INFECTION. THE DEVICE APPROVAL IS FOR USE OF AN 8-POINT CALIBRATION CURVE WITH MANUAL CALCULATIONS.